Treatment Strategies for Treatment-Resistant OCD

When a patient does not respond to an SSRI trial, what is the best strategy—increase the dose, augment with another agent, or switch to another SSRI? In this interview, Dr. Hudak discusses dosing strategies and the treatment of patients with OCD and comorbid psychiatric conditions.  <p>Guest: Robert Hudak, M.D. <br /> Interviewer: Mohan Gautam, D.O. <br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><strong><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC143"> Learn more about Premium Membership here</a></strong></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/treatment-resistant-obsessive-compulsive-disorder-interview-2608?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC143"> <strong>Earn 0.5 CMEs: Treatment-Resistant Obsessive-Compulsive Disorder - Interview with Robert Hudak, M.D.</strong></a></li> </ul>